Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Completed · Phase 4

Conditions studied: Detrusor Hyperreflexia

In brief

This study will evaluate the safety and effectiveness of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in children who have a neurological condition (e.g. spina bifida) that contributes to their overactive bladder.

Key facts

Study ID

NCT00224016

Run by

Watson Pharmaceuticals

People needed

57

Starts

2004-12-01

Expected to finish

2008-09-01

Last updated by the study team

2012-02-09

Who can join

Age: 6 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pediatric patient with a diagnosis of detrusor overactivity associated with a neurological condition;
• Use clean intermittent catheterization
• On stable dose of oral oxybutynin before participation

You may not qualify if…

• Have one or more treatable conditions, other than neurogenic bladder dysfunction, that may cause urinary incontinence or urgency
• Have any medical condition that precludes their participation in the study or may confound the outcome of the study

Where it is running

• Watson Investigational Site — Little Rock, Arkansas, United States
• Watson Investigational Site — Orange County, California, United States
• Watson Investigational Site — San Diego, California, United States
• Watson Investigational Site — Denver, Colorado, United States
• Watson Investigational Site — Washington D.C., District of Columbia, United States
• Watson Investigational Site — Detroit, Michigan, United States
• Watson Investigational Site — Minneapolis, Minnesota, United States
• Watson Investigational Site — Jackson, Mississippi, United States
• Watson Investigational Site — Kansas City, Missouri, United States
• Watson Investigational Site — St Louis, Missouri, United States
• Watson Investigational Site — Voorhees Township, New Jersey, United States
• Watson Investigational Site — Albany, New York, United States
• Watson Investigational Site — Buffalo, New York, United States
• Watson Investigational Site — Poughkeepsie, New York, United States
• Watson Investigational Site — Ashville, North Carolina, United States
• Watson Investigational Site — Durham, North Carolina, United States
• Watson Investigational Site — Columbus, Ohio, United States
• Watson Investigational Site — Oklahoma City, Oklahoma, United States
• Watson Investigational Site — Hershy, Pennsylvania, United States
• Watson Investigational Site — Dallas, Texas, United States
• Watson Investigational Site — Houston, Texas, United States
• Watson Investigational Site — Plano, Texas, United States
• Watson Investigational Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.